Trials / Conditions / Bile Duct Adenocarcinoma

Bile Duct Adenocarcinoma

4 registered clinical trials studyying Bile Duct Adenocarcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories NCT07120295	University of Colorado, Denver	Phase 4
Unknown	Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma NCT06092645	Zhejiang Cancer Hospital	Phase 2
Unknown	Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations NCT04042831	Academic and Community Cancer Research United	Phase 2
Withdrawn	Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That NCT03117855	City of Hope Medical Center	Phase 1